Roche secures EU approval for wider use of lung cancer drug

04/29/2010 | Reuters

Roche Holding said European regulators approved Tarceva as a maintenance treatment for advanced nonsmall-cell lung cancer. The drug received FDA approval earlier this month for this indication. Roche also said its Type 2 diabetes treatment taspoglutide yielded positive results in a late-stage trial.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA